FDA Calendar for Biodel Inc (BIOD)

| Register (free)
Biodel Inc. (Biodel) is a development-stage company. The Company is a specialty biopharmaceutical company focused on the development and commercialization of treatments for diabetes. The Company develops its product candidates by applying its proprietary formulation technologies to existing drugs in order to improve their therapeutic profiles. The Company’s initial development efforts are focused on peptide hormones. The Company’s product candidate, VIAject, has been studied in two pivotal Phase III clinical trials for the treatment of patients with Type 1 and Type 2 diabetes. In addition to VIAject, the Company is developing VIAtab, a sublingual or below the tongue tablet formulation of insulin. The Company develops its product candidates utilizing its proprietary VIAdel technology, which allows it to study the interaction between peptide hormones and small molecules.


Drug Pipeline

Drug NameType Of DrugFDA StatusDrug Phase
VIAject Diabetes Pending DecisionNDA


Events

No future events listed at this time, please check back later.
1 past event(s) found. Click here to view them.

Add New Event

In order to write a comment you must first login.

Login or Register (for free!)

Add Event

BIOD

$0.60
-0.0105 -1.71%
2/3/2012 3:59:00 PM

Sponsors

Other Links